Cargando…

Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies

In this post hoc analysis of the 63 patients with secondary bacteremia enrolled in the 3 omadacycline phase 3 studies of acute bacterial skin/skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP), we determined that omadacycline is a viable therapeutic option for appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakoulas, George, Eckburg, Paul B, Amodio-Groton, Maria, Manley, Amy, Tzanis, Evan, Das, Anita F, Noble, Robert, McGovern, Paul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212941/
https://www.ncbi.nlm.nih.gov/pubmed/34160473
http://dx.doi.org/10.1093/ofid/ofab136
_version_ 1783709735357251584
author Sakoulas, George
Eckburg, Paul B
Amodio-Groton, Maria
Manley, Amy
Tzanis, Evan
Das, Anita F
Noble, Robert
McGovern, Paul C
author_facet Sakoulas, George
Eckburg, Paul B
Amodio-Groton, Maria
Manley, Amy
Tzanis, Evan
Das, Anita F
Noble, Robert
McGovern, Paul C
author_sort Sakoulas, George
collection PubMed
description In this post hoc analysis of the 63 patients with secondary bacteremia enrolled in the 3 omadacycline phase 3 studies of acute bacterial skin/skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP), we determined that omadacycline is a viable therapeutic option for appropriate patients with secondary bacteremia.
format Online
Article
Text
id pubmed-8212941
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82129412021-06-21 Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies Sakoulas, George Eckburg, Paul B Amodio-Groton, Maria Manley, Amy Tzanis, Evan Das, Anita F Noble, Robert McGovern, Paul C Open Forum Infect Dis Brief Reports In this post hoc analysis of the 63 patients with secondary bacteremia enrolled in the 3 omadacycline phase 3 studies of acute bacterial skin/skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP), we determined that omadacycline is a viable therapeutic option for appropriate patients with secondary bacteremia. Oxford University Press 2021-06-18 /pmc/articles/PMC8212941/ /pubmed/34160473 http://dx.doi.org/10.1093/ofid/ofab136 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Sakoulas, George
Eckburg, Paul B
Amodio-Groton, Maria
Manley, Amy
Tzanis, Evan
Das, Anita F
Noble, Robert
McGovern, Paul C
Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
title Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
title_full Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
title_fullStr Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
title_full_unstemmed Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
title_short Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
title_sort clinical efficacy of patients with secondary bacteremia treated with omadacycline: results from phase 3 acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia studies
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212941/
https://www.ncbi.nlm.nih.gov/pubmed/34160473
http://dx.doi.org/10.1093/ofid/ofab136
work_keys_str_mv AT sakoulasgeorge clinicalefficacyofpatientswithsecondarybacteremiatreatedwithomadacyclineresultsfromphase3acutebacterialskinandskinstructureinfectionsandcommunityacquiredbacterialpneumoniastudies
AT eckburgpaulb clinicalefficacyofpatientswithsecondarybacteremiatreatedwithomadacyclineresultsfromphase3acutebacterialskinandskinstructureinfectionsandcommunityacquiredbacterialpneumoniastudies
AT amodiogrotonmaria clinicalefficacyofpatientswithsecondarybacteremiatreatedwithomadacyclineresultsfromphase3acutebacterialskinandskinstructureinfectionsandcommunityacquiredbacterialpneumoniastudies
AT manleyamy clinicalefficacyofpatientswithsecondarybacteremiatreatedwithomadacyclineresultsfromphase3acutebacterialskinandskinstructureinfectionsandcommunityacquiredbacterialpneumoniastudies
AT tzanisevan clinicalefficacyofpatientswithsecondarybacteremiatreatedwithomadacyclineresultsfromphase3acutebacterialskinandskinstructureinfectionsandcommunityacquiredbacterialpneumoniastudies
AT dasanitaf clinicalefficacyofpatientswithsecondarybacteremiatreatedwithomadacyclineresultsfromphase3acutebacterialskinandskinstructureinfectionsandcommunityacquiredbacterialpneumoniastudies
AT noblerobert clinicalefficacyofpatientswithsecondarybacteremiatreatedwithomadacyclineresultsfromphase3acutebacterialskinandskinstructureinfectionsandcommunityacquiredbacterialpneumoniastudies
AT mcgovernpaulc clinicalefficacyofpatientswithsecondarybacteremiatreatedwithomadacyclineresultsfromphase3acutebacterialskinandskinstructureinfectionsandcommunityacquiredbacterialpneumoniastudies